Medtronic (NYSE:MDT) CFO Gary Lee Ellis sold 4,246 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, April 1st. Medtronic, Inc. (NYSE:MDT) shares after opening at $62.09 moved to $62.41 on last trade day and at the end of the day closed at $62.31. Company price to sales ratio in past twelve months was calculated as 3.69 and price to cash ratio as 4.56. Medtronic, Inc. (NYSE:MDT) showed a positive weekly performance of 5.79%.
Stryker Corporation (NYSE:SYK) announced that Curtis E. Hall, Vice President and Chief Legal Officer, has elected to shift to a part-time role as Senior Legal Counsel, and transition the leadership of the Corporation’s Legal and Compliance function to Michael D. Hutchinson, General Counsel. Stryker Corporation (NYSE:SYK) shares advanced 2.24% in last trading session and ended the day on $84.13. SYK return on equity ratio is recorded as 11.50% and its return on assets is 6.80%. Stryker Corporation (NYSE:SYK) yearly performance is 30.31%.
Retrophin (NASDAQ:RTRX) CEO Martin Shkreli bought 10,800 shares of the stock in a transaction dated Wednesday, April 2nd. The stock was purchased at an average cost of $22.28 per share, with a total value of $240,624.00. Following the completion of the acquisition, the chief executive officer now directly owns 2,952,180 shares in the company, valued at approximately $65,774,570. Retrophin Inc (NASDAQ:RTRX) shares moved down -9.63% in last trading session and was closed at $21.11 while trading in range of $20.89 – $24.25 – Retrophin Inc (NASDAQ:RTRX) year to date (YTD) performance is 201.57%.
Intuitive Surgical Inc. (NASDAQ:ISRG) shares advanced 3.5%. The stock rose for an eighth session after it received clearance for its da Vinci Xi Surgical System from the Food and Drug Administration. Intuitive Surgical, Inc. (NASDAQ:ISRG) weekly performance is 26.14%. On last trading day company shares ended up $540.63. Intuitive Surgical, Inc. (NASDAQ:ISRG) distance from 50-day simple moving average (SMA50) is 24.71%. Analysts mean target price for the company is $437.87.